Ling Geoffrey M.D. 4
4 · CATALYST BIOSCIENCES, INC. · Filed Jan 7, 2022
Insider Transaction Report
Form 4
Ling Geoffrey M.D.
Director
Transactions
- Award
Common Stock
2022-01-07+12,855→ 31,790 total
Footnotes (1)
- [F1]Represents shares of common stock received in lieu of fees.